NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹36 Cr | ₹20 Cr | ₹35 Cr | ₹14 Cr | ₹27 Cr |
What is the latest Cash Flow from Operating Activities ratio of NGL FINECHEM ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹27 Cr |
How is Cash Flow from Operating Activities of NGL FINECHEM Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | 75.04 | |
| Mar2024 | ₹20 Cr | -42.00 | |
| Mar2023 | ₹35 Cr | 155.23 | |
| Mar2022 | ₹14 Cr | -49.46 | |
| Mar2021 | ₹27 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,444.2 Cr | 4.6% | 3.5% | 105.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 4.6% |
3.5% |
105.7% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses